New sulfonamides are usually tested against bacteria or diseases wherein the older drugs work satisfactorily. There seems to be little advantage in testing new drugs only against those bacteria in which older sulfonamides have already proved their worth. Since the older sulfonamides exert little action on diseases caused by some gram-negative organisms, it seemed advisable to attempt to find one which might prove efficacious in treatment of typhoid and paratyphoid infections. Four sulfonamides which were tested previously (Schweinburg and Yetwin, 1944) were not satisfactory so we decided to investigate the potentialities of sulfamethazine. ' We do not overestimate conclusions as to clinical application that may be drawn from test tube experiments. Although some believe there is no quantitative relationship between in vitro and in vivo action (Marshall, Litchfield, White, Bratton, and Shepherd, 1942) , other recent papers reveal a surprising parallelism between resistance in vitro and unsuccessful treatment (Cohn, Steer, and Seijo, 1942; Spink and Vivino, 1944; Winchester and Whittle, 1944) . If a drug is an effective bactericidal and bacteriostatic agent in the test tube, it may or may not be effective in vivo. But it cannot be expected that a drug ineffective against a certain bacterium in vitro will prove successful in combating a disease caused by that organism.
Two new sulfa drugs, sulfapyrazine and sulfamethazine, are now in use, both apparently effective against gram-positive and gram-negative cocci. At the present time the output of sulfapyrazine is apparently limited and we therefore regret our inability to obtain it for examination upon the enteric organisms. The other sulfonamide, sulfamethazine (called sulphamezathine by the English), is dimethylsulfadiazine and consequently not only related to sulfadiazine but also to sulfamerazine, which is monomethylsulfadiazine. The in vitro action of sulfamethazine closely resembles that of sulfapyridine when tested against streptococci and pneumococci (Rose, Martin, and Bevan, 1943) . Clinical trials with both drugs have shown good results in dysentery but no effect against the Salmonella infections (Hardy and Watt, 1944) . Sulfamethazine is probably the best of all sulfonamides in the treatment of pneumonia (Page, 1944) ; it apparently has some advantages over the other sulfonamides now in use (Rose, (Jenning and Patterson, 1942; PakenhamWalsh, 1943; Hardy and Watt, 1944; Page, 1944) .
Some investigators have shown that if one sulfonamide proves effective against a particular bacterium, the others will follow suit, although there may be slight variations of the necessary concentrations. Conversely, if one sulfonamide is ineffective against a certain organism, the others will also prove ineffective (Wyss, Grubagh, and Schmelkes, 1942) . Although we are in accord with this opinion, we found, in the test tube, marked differences in the effective concentrations of various sulfonamides on different enteric pathogens (Schweinburg and Yetwin, 1944) .
MATERLkS AND TECHNIQUE
The three drugs compared (sulfamethazine, sulfadiazine, and sulfamerazine) were dissolved in sterile nutrient broth containing 0.5 per cent peptone. Clear solutions were obtained in concentrations as high as 2.0 per cent with a pH of 7.6, using heat for complete dissolution. The 2.0 per cent solution of sulfamerazine contained small amounts of undissolved powder at room temperature, making gentle heating necessary prior to use. Sulfadiazine and sulfamethazine remained in complete solution at the 2.0 per cent strength. All lower drug concentrations were prepared by diluting these stock solutions with appropriate amounts of sterile broth of the same pH. The concentrations used were: 2.0 ,1.5, 1.0, 0.75, 0.50, 0.25, 0.10, 0.050, 0.025, and 0.010 per cent. The following bacteria were examined: Escherichia coli, Eberthella typho8a, Salmonella paratyphi, SalmoneUa 8chottmuelleri, Salmonella var. enteritidis, Salmonella choleraesui8, Shigella dysenteriae, Shigella paradyserteride var. Flexner, Shigella paradysenteriae var. Hiss, and Shigella sonnei.
Twenty-four-hour cultures were prepared on agar slants. A loopful of the growth was transferred into 5 ml of nutrient broth (pH 7.6) and incubated for 24 hours. Dilutions of this growth were made in isotonic saline and standardized against a nephelometer so that each bacterial suspension contained 16 million bacteria per ml. We found that the same nephelometer could be used for different bacteria without making an appreciable error. We ascertained by plating out that the same degree of cloudiness in tubes containing the various bacteria always meant approximately the same number of organisms. The standardized suspensions were diluted 1:100 with saline, and 0.1 ml (equivalent to 16,000 bacteria) was added to 0.9 ml of the respective drug concentrations, and also to a tube of 0.9 ml nutrient broth serving as control. The number of bacteria chosen was an arbitrary one. The effect of drug concentration on bacteria seems to vary with the size of the inoculum (Pike and Acton, 1942 )-a problem we will deal with in detail in a paper to follow. After 24 hours the tubes were read for degree of cloudiness, an'd 0.1 ml of suitable dilutions was mixed with 10 ml of melted agar, plated, and counted after another 24 hours of incubation. The duration SULFAMETHAZINE: ACTION ON ENT!RnIC PATHOGENS of contact may influence the action of the drug on bacteria-a factor which will also be considered in the next report.
Following the procedure outlined, we determined the bactericidal action of the three drugs on each of the bacteria examined. We also established the lowest concentration at which bacteriostasis still occurred by comparing the number of bacteria grown in lower drug concentrations with the number found in the broth control. Each drug was tested against the individual bacterium at least 10 times. In a few instances in which the results were not uniform from the very beginning, as many as 20 experiments were performed; but in no case did the bactericidal or bacteriostatic titer deviate for more than one tube from the final result. The following protocol (table 1) is an example of the procedure followed in each of the 340 tests. The results obtained from our trials are listed in table 2. They are valid for the number of bacteria we employed, for the applied time, for the particular strain of each species tested, and for the medium used. We are well aware, however, that all conclusions drawn from these test tube experiments are of limited value as far as the action of sulfonamides in a diseased organism is concerned. The results show that 9 of the 10 bacteria tested are destroyed in lower concentrations of sulfamethazine than of sulfadiazine or sulfamerazine. The only exception is Shigella dysenteriae, in which both sulfadiazine and sulfamerazine act better, the latter being by far the most effective. In 7 of the 10 organisms, sulfamethazine also exhibits the best bacteriostatic effect. Of the remaining three organisms, the Flexner strain is equally affected by sulfamethazine and sulfamerazine, sulfadiazine being least effective. Against Eberthella typhosa, sulfadia- Compared with the phthalyl derivatives reported upon earlier (Schweinburg and Yetwin, 1944) , it is seen that the in vitro bactericidal action of sulfamethazine (Long, 1941; Cutting and Robson, 1942; Kirby and Rantz, 1942) and of the Salmonella infections (Bornstein and Strauss, 1941; Bomstein, 1943) .
